Article
Author(s):
Cymbalta is a serotonin and norepinephrine reuptake inhibitor indicated for major depressive disorder and anxiety, diabetic peripheral neuropathy, fibromyalgia, and chronic pain related to the muscles and bones.
Medication Pearl of the Day: Duloxetine Hydrochloride (Cymbalta)
Indication: Cymbalta is a serotonin and norepinephrine reuptake inhibitor indicated for major depressive disorder and anxiety, diabetic peripheral neuropathy, fibromyalgia, and chronic pain related to the muscles and bones.
Insight:
Source: Cymbalta (duloxetine hydrochloride) capsules (fda.gov)
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children At Increased Risk
Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease